Stabilizing Isotope Supply: Nusano’s Chris Lowe

06/11/2025 20 min Episodio 28
Stabilizing Isotope Supply: Nusano’s Chris Lowe

Listen "Stabilizing Isotope Supply: Nusano’s Chris Lowe"

Episode Synopsis

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Chris Lowe, CEO of Nusano, a medical technology company addressing critical shortages in the global radioisotope market. Nusano’s proprietary ion source technology enables the efficient and sustainable production of multiple isotopes simultaneously, supporting cancer therapies, diagnostic imaging, and other essential applications. 
Chris brings more than 20 years of executive experience in healthcare and finance, having raised over $500 million in private and public financing and having completed more than $1 billion in M&A transactions. Prior to Nusano, he served as CFO and COO of Cortexyme, where he guided the company through its IPO and eventual acquisition.
Chris supports American Cancer Society. To learn more about this organization click here.
I am your host RJ Lumba. We hope you enjoy the show. If you like the episode click to follow.